Madrigal Pharmaceuticals (MDGL) Q1 2025 Earnings

26FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-7.54
-5.93
-4.32
-2.71

Details

Expected EPS
-3.919511
Actual EPS
-2.71
Surprise EPS
1.21
Surprise Percent
+30.86%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -2.71 per share for Q1 2025.

0 Comments

Share your thoughts